已收盤 07-14 16:00:00 美东时间
0.000
0.00%
Eisai and Biogen announced new three-year real-world findings from the LEADER study, showing LEQEMBI reduced the rate of progression to moderate or severe Alzheimer's disease by 76% compared to a matched cohort. Over 80% of patients remained stable or improved, with 95% estimated to remain in early stages after three years. Amyloid clearance was observed in 77% of patients, and safety profiles were consistent across diverse settings. The findings...
11-18 16:00
Tango Therapeutics reported promising Phase 1/2 data for vopimetostat plus daraxonrasib in pancreatic cancer, achieving an 82% ORR and 88% 9-month PFS. A registrational Phase 3 study is planned for 1H 2027. Vopimetostat data in NSCLC and TNG456 data in NSCLC, glioblastoma, and other cancers will be disclosed in January 2027. Cash position stands at $977.5 million as of September 30, 2026.
11-09 12:00
Ethan Allen reaffirms its five director nominees, disagreeing with ISS's recommendation to replace two of them. ISS questions DGB's proposal to replace the entire board, noting limited progress in their CEO search. Ethan Allen emphasizes the importance of continuity in leadership for a smooth CEO transition and urges shareholders to vote for their nominees on the BLUE proxy card.
10-27 13:09
Philips and the University Medical Center Groningen have launched the five-year EXIT-CVD project, co-funded by the European Union and industry partners, to transform cardiovascular disease detection, monitoring, and treatment. The project involves 42 partners across 17 countries, conducting 22 clinical studies with over 14,000 patients. It focuses on three key exit points: early detection, personalized interventions, and advanced therapies. The p...
10-15 08:00
New phase 3 data found that plaque psoriasis patients treated with Johnson & Johnson's (JNJ) Icotyde (icotrokinra) saw high levels of skin clearance after more than two years of treatment. In the pha...
10-09 23:54
BioArctic AB Class B ( ($SE:BIOA.B) ) has shared an announcement. Real-world da...
07-14 23:32